This new position, located at Reata Headquarters in Dallas, Texas, reports to the Chief Medical Officer / Vice President of Clinical and Regulatory Affairs. Your primary responsibility will be to provide the clinical development expertise, management and leadership to direct drug research activities (Phase II – III) resulting in high quality, cost effective programs leading to timely regulatory submissions and approvals.

Your responsibilities will include: clinical protocol design and study management; target indications and investigators for clinical research projects; lead investigator teams in protocol design; develop/deliver presentations to key audiences; develop credible relationships with physician leaders, medical directors, investigators and regulatory professionals; medical reporting and special projects; chair and organize team and investigator meetings; select monitors and CROs for monitoring and reporting clinical trials; evaluate clinical data; direct final study report writing and manuscript preparation and maintain all aspects of medical safety and clinical compliance.

Candidate Requirements:

We seek an MD, PhD or MD/PhD with 5-7 years of experience in Phase II-III clinical research.

Therapeutic experience in oncology and / or inflammation coupled with global experience with pivotal, multi-site clinical trials is highly desirable.

We prefer a professional with global drug development experience from a quality ethical pharmaceutical or biotechnology company that has a reputation for high quality productive clinical research

Experience with clinical data management and pharmacovigilance is a plus.

For the best fit you should be a results-oriented team player with strong interpersonal and communications skills, capable of working collaboratively with colleagues.

Compensation:

A compensation package will be designed to attract outstanding talent and will include a base salary, performance bonus, and appropriate stock incentives.